Nektar Posted Promising Alopecia Results. Here's Why It Took A 20%-Plus Hit.

Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients. The post Nektar Posted Promising Alopecia Results. Here's Why It Took A 20%-Plus Hit. appeared first on Investor's Business Daily.

CryptoAlerta — análise de criptomoedas e mercado em tempo real